Joseph Lo

Dr. Joseph Lo

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2008 in Neural Networks
Verified
Journal Article
Closed access
MMMaciej A. Mazurowski
Maciej A. Mazurowski
PHPiotr A. Habas
Piotr A. Habas
JZJacek M. Zurada
Jacek M. Zurada
JLJoseph Lo
Joseph Lo
JBJay A. Baker
Jay A. Baker
GTGeorgia D. Tourassi
Georgia D. Tourassi

11 April 2020 in Journal of Medical Imaging
Verified
Journal Article
Open access
PDF file
EAEhsan Abadi
Ehsan Abadi
WSWilliam P. Segars
William P. Segars
BTBenjamin M. W. Tsui
Benjamin M. W. Tsui
PKPaul E Kinahan
Paul E Kinahan
NBNick Bottenus
Nick Bottenus
ESEhsan Samei
Ehsan Samei
Medical imaging involves some of the most beneficial and advanced technologies used in medicine today. However, the design and implementation of new imaging technology is incredibly complex. Doing so through clinical trials (experiments using human subjects) is often not practical or definitive due to ethical limitations, expense, time requirements, difficulty in accruing enough subjects, or a fundamental lack of ground truth (knowledge of the exact anatomy and condition of the patient). Most current approaches to assess imaging technologies outside of clinical trials rely on simplistic physical phantoms, the results from which cannot readily predict clinical efficacy. Meanwhile, the complexity of medical imaging technologies has continued to accelerate, outpacing our ability to assess them and optimize their design and clinical use. By the time we have consummated the ideal trials, the technology has moved on again. Therefore, we either work with “old validated” technology that may be less effective or put patients potentially at risk with newer unvalidated technology.

1 September 2013 in International Journal of Radiation Oncology, Biology, Physics
Verified
Journal Article
Closed access
DGDavid Good
David Good
JLJoseph Lo
Joseph Lo
WLW. Robert Lee
W. Robert Lee
QWQ. Jackie Wu
Q. Jackie Wu
FYFang-Fang Yin
Fang-Fang Yin
SDShiva K. Das
Shiva K. Das

15 December 2021 in Nature Machine Intelligence
Verified
Journal Article
Closed access
PDF file
ABAlina Jade Barnett
Alina Jade Barnett
FSFides Regina Schwartz
Fides Regina Schwartz
CTChaofan Tao
Chaofan Tao
CCChaofan Chen
Chaofan Chen
YRYinhao Ren
Yinhao Ren
CRCynthia Rudin
Cynthia Rudin

2 May 2011 in Medical Physics
Verified
Journal Article
Open access
VCVorakarn Chanyavanich
Vorakarn Chanyavanich
SDShiva K. Das
Shiva K. Das
WLWilliam R. Lee
William R. Lee
JLJoseph Lo
Joseph Lo
To demonstrate the feasibility of using a knowledge base of prior treatment plans to generate new prostate intensity modulated radiation therapy (IMRT) plans. Each new case would be matched against others in the knowledge base. Once the best match is identified, that clinically approved plan is used to generate the new plan. A database of 100 prostate IMRT treatment plans was assembled into an information-theoretic system. An algorithm based on mutual information was implemented to identify similar patient cases by matching 2D beam's eye view projections of contours. Ten randomly selected query cases were each matched with the most similar case from the database of prior clinically approved plans. Treatment parameters from the matched case were used to develop new treatment plans. A comparison of the differences in the dose-volume histograms between the new and the original treatment plans were analyzed. On average, the new knowledge-based plan is capable of achieving very comparable planning target volume coverage as the original plan, to within 2% as evaluated for D98, D95, and D1. Similarly, the dose to the rectum and dose to the bladder are also comparable to the original plan. For the rectum, the mean and standard deviation of the dose percentage differences for D20, D30, and D50 are 1.8% +/- 8.5%, -2.5% +/- 13.9%, and -13.9% +/- 23.6%, respectively. For the bladder, the mean and standard deviation of the dose percentage differences for D20, D30, and D50 are -5.9% +/- 10.8%, -12.2% +/- 14.6%, and -24.9% +/- 21.2%, respectively. A negative percentage difference indicates that the new plan has greater dose sparing as compared to the original plan. The authors demonstrate a knowledge-based approach of using prior clinically approved treatment plans to generate clinically acceptable treatment plans of high quality. This semiautomated approach has the potential to improve the efficiency of the treatment planning process while ensuring that high quality plans are developed.

1 October 2003 in American Journal of Roentgenology
Verified
Journal Article
Closed access
JBJay A. Baker
Jay A. Baker
EREric L. Rosen
Eric L. Rosen
JLJoseph Lo
Joseph Lo
EGEdgardo I. Gimenez
Edgardo I. Gimenez
RWRuth Walsh
Ruth Walsh
MSMary Scott Soo
Mary Scott Soo
OBJECTIVE. Computer-aided detection (CAD) algorithms have successfully revealed breast masses and microcalcifications on screening mammography. The purpose of our study was to evaluate the sensitivity of commercially available CAD systems for revealing architectural distortion, the third most common appearance of breast cancer.MATERIALS AND METHODS. Two commercially available CAD systems were used to evaluate screening mammograms obtained in 43 patients with 45 mammographically detected regions of architectural distortion. For each CAD system, we determined the sensitivity for revealing architectural distortion on at least one image of the two-view mammographic examination (case sensitivity) and for each individual mammogram (image sensitivity). Surgical biopsy results were available for each case of architectural distortion.RESULTS. Architectural distortion was deemed present and actionable by a panel of expert breast imagers in 80 views of the 45 cases. One CAD system detected distortion in 22 of 45 cas...